Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer

Receptor-activator of nuclear-factor –κB-ligand (RANKL) and its receptor RANK have been recently identified as key players in breast cancer bone metastases. Since Circulating Tumor Cells (CTCs) are considered a crucial step of metastatic process, we explored RANK expression on CTCs in metastatic bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantano, Francesco, Rossi, Elisabetta, Iuliani, Michele, Facchinetti, Antonella, Simonetti, Sonia, Ribelli, Giulia, Zoccoli, Alice, Vincenzi, Bruno, Tonini, Giuseppe, Zamarchi, Rita, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987166/
https://www.ncbi.nlm.nih.gov/pubmed/31992773
http://dx.doi.org/10.1038/s41598-020-58339-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987166/
https://www.ncbi.nlm.nih.gov/pubmed/31992773
http://dx.doi.org/10.1038/s41598-020-58339-2

Ejemplares similares